Concepedia

Howard Levy

HL

82

Publications

8.6K

Citations

44

H-Index

1927

Active since

Affiliations

University of New Mexico(Current)

University of the Witwatersrand

Eli Lilly (United States)

South African Institute for Medical Research

Howard Levy is an author at University of New Mexico specializing in medicine, sepsis, and critical care medicine.

ORCID

Top concepts

Publications per year

1927–2021

82

Publications

82

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

Edward Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine · 2005 · 882 citations · Full text

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

Steven M. Opal, Charles J. Fisher, Jean-François Dhainaut et al. · Critical Care Medicine · 1997 · 856 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez et al. · PubMed · 1998 · 628 citations

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Simon Nadel, Brahm Goldstein, Mark D. Williams et al. · The Lancet · 2007 · 499 citations

, , +5

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez et al. · The Lancet · 1998 · 497 citations

, , +6

Rows per page

1–5 of 82